logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

医疗保健精选——Moderna日本早期新冠疫苗试验接种首位参与者;基因编辑公司股价攀升

Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest

Jan 21, 2021

Life Science

医疗保健精选—以色列和辉瑞公司分享新冠疫苗数据,Grifols公司将试验新冠肺炎的新型免疫球蛋白疗法

Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September;Grifols to trial new immunoglobulin therapy against COVID-19

Jan 18, 2021

Life Science

Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst

Jan 15, 2021

Life Science

医疗精选——分析师看好强生单剂量新冠疫苗;礼来在研阿尔茨海默症治疗药物显示疗效,股价上涨20%

Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study

Jan 12, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

Dec 22, 2020

Life Science

医疗保健精选——美国人可能会在周一开始接种辉瑞疫苗,COVID-19抗体疗法开发商AbCellera Bio公开募股发行价超过20美元

Healthcare Roundup – Americans could begin getting Pfizer vaccine on Monday, COVID-19 antibody therapy developer AbCellera Bio prices IPO above range at $20

Dec 11, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces Adoption of Advance Notice Bylaw and Shareholder Rights Plan as well as Transitions in its Board of Directors

Dec 11, 2020

Life Science

医疗保健精选——加拿大政府增订Moderna新冠疫苗,艾伯维Imbruvica对未经治疗的慢性淋巴细胞性白血病有显著疗效

Healthcare Roundup – Moderna’s COVID vaccine deal gets a boost from Canada, AbbVie’s Imbruvica shows treatment benefit in untreated chronic lymphocytic leukemia

Dec 7, 2020

Life Science

医疗保健精选——众议院为大麻合法化问题进行历史性投票,Moderna向以色列供应600万剂新冠疫苗

Healthcare Roundup – House gears up for historic vote on cannabis legalization, Moderna boosts COVID-19 vaccine deal with Israel to 6M doses

Dec 5, 2020

Life Science

Healthcare Roundup – U.S. could immunize one-third of population, JD Health raises $3.5B in Hong Kong IPO

Dec 3, 2020

Life Science

Healthcare Roundup – Sorrento Therapeutics rallies, Exelixis/Takeda’s Cabometyx Ok’d in Japan for liver cancer

Nov 27, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

Nov 27, 2020

Life Science

医疗保健精选——阿斯利康可能会进行新的全球疫苗测试,Equinllix暂停新冠肺炎疗法的后期试验

Healthcare Roundup – CEO says AstraZeneca likely to run new global vaccine test, Equillium nixes plan to start late-stage trials of COVID-19 treatment

Nov 26, 2020

Life Science

医疗保健精选——美国疾控中心警告不要在新冠激增期间进行感恩节旅行,世卫组织建议医生不要使用瑞德昔韦治疗新冠肺炎

Healthcare Roundup – CDC warns against Thanksgiving travel amid COVID spike, WHO recommends doctors not use remdesivir to treat COVID-19

Nov 19, 2020

Life Science

医疗保健精选——辉瑞和BioNTech新冠疫苗最终有效率达95%;FDA批准首个在家使用的新冠病毒试剂

Healthcare Roundup – Pfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis; FDA authorizes first at-home rapid COVID-19 test

Nov 18, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership

Nov 10, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Closing of Debt Settlement

Oct 28, 2020

Life Science

Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx

Oct 27, 2020

Life Science

  • ‹‹ Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada